![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 25445 |
FusionGeneSummary for OPHN1_MAOA |
![]() |
Fusion gene information | Fusion gene name: OPHN1_MAOA | Fusion gene ID: 25445 | Hgene | Tgene | Gene symbol | OPHN1 | MAOA | Gene ID | 4983 | 4128 |
Gene name | oligophrenin 1 | monoamine oxidase A | |
Synonyms | ARHGAP41|MRX60|OPN1 | BRNRS|MAO-A | |
Cytomap | Xq12 | Xp11.3 | |
Type of gene | protein-coding | protein-coding | |
Description | oligophrenin-1mental retardation, X-linked 60oligophrenin-1, Rho-GTPase activating protein | amine oxidase [flavin-containing] Amonoamine oxidase type A | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | O60890 | P21397 | |
Ensembl transtripts involved in fusion gene | ENST00000355520, ENST00000540071, ENST00000484842, | ENST00000338702, ENST00000542639, ENST00000497485, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 2 X 2=8 |
# samples | 3 | 2 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: OPHN1 [Title/Abstract] AND MAOA [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-C8-A273-01A | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000355520 | ENST00000338702 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
Frame-shift | ENST00000355520 | ENST00000542639 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
5CDS-3UTR | ENST00000355520 | ENST00000497485 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
Frame-shift | ENST00000540071 | ENST00000338702 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
Frame-shift | ENST00000540071 | ENST00000542639 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
5CDS-3UTR | ENST00000540071 | ENST00000497485 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
intron-3CDS | ENST00000484842 | ENST00000338702 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
intron-3CDS | ENST00000484842 | ENST00000542639 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
intron-3UTR | ENST00000484842 | ENST00000497485 | OPHN1 | chrX | 67412761 | - | MAOA | chrX | 43590488 | + |
Top |
FusionProtFeatures for OPHN1_MAOA |
![]() |
Hgene | Tgene |
OPHN1 | MAOA |
Stimulates GTP hydrolysis of members of the Rho family.Its action on RHOA activity and signaling is implicated in growthand stabilization of dendritic spines, and therefore in synapticfunction. Critical for the stabilization of AMPA receptors atpostsynaptic sites. Critical for the regulation of synapticvesicle endocytosis at presynaptic terminals. Required for thelocalization of NR1D1 to dendrites, can suppress its repressoractivity and protect it from proteasomal degradation (Bysimilarity). {ECO:0000250}. | Catalyzes the oxidative deamination of biogenic andxenobiotic amines and has important functions in the metabolism ofneuroactive and vasoactive amines in the central nervous systemand peripheral tissues. MAOA preferentially oxidizes biogenicamines such as 5-hydroxytryptamine (5-HT), norepinephrine andepinephrine. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for OPHN1_MAOA |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for OPHN1_MAOA |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
OPHN1 | RHOA, RAC1, CDC42, NXF1, ARHGAP26, TRIM25 | MAOA | NDRG1, COQ9, MAOB, MIEF1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for OPHN1_MAOA |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | MAOA | P21397 | DB00780 | Phenelzine | Amine oxidase [flavin-containing] A | small molecule | approved |
Tgene | MAOA | P21397 | DB00805 | Minaprine | Amine oxidase [flavin-containing] A | small molecule | approved |
Tgene | MAOA | P21397 | DB01247 | Isocarboxazid | Amine oxidase [flavin-containing] A | small molecule | approved |
Tgene | MAOA | P21397 | DB01626 | Pargyline | Amine oxidase [flavin-containing] A | small molecule | approved |
Tgene | MAOA | P21397 | DB09245 | Toloxatone | Amine oxidase [flavin-containing] A | small molecule | approved |
Tgene | MAOA | P21397 | DB00191 | Phentermine | Amine oxidase [flavin-containing] A | small molecule | approved|illicit |
Tgene | MAOA | P21397 | DB01577 | Methamphetamine | Amine oxidase [flavin-containing] A | small molecule | approved|illicit |
Tgene | MAOA | P21397 | DB00182 | Amphetamine | Amine oxidase [flavin-containing] A | small molecule | approved|illicit|investigational |
Tgene | MAOA | P21397 | DB00752 | Tranylcypromine | Amine oxidase [flavin-containing] A | small molecule | approved|investigational |
Tgene | MAOA | P21397 | DB00909 | Zonisamide | Amine oxidase [flavin-containing] A | small molecule | approved|investigational |
Tgene | MAOA | P21397 | DB01168 | Procarbazine | Amine oxidase [flavin-containing] A | small molecule | approved|investigational |
Tgene | MAOA | P21397 | DB01171 | Moclobemide | Amine oxidase [flavin-containing] A | small molecule | approved|investigational |
Tgene | MAOA | P21397 | DB01171 | Moclobemide | Amine oxidase [flavin-containing] A | small molecule | approved|investigational |
Tgene | MAOA | P21397 | DB00721 | Procaine | Amine oxidase [flavin-containing] A | small molecule | approved|investigational|vet_approved |
Tgene | MAOA | P21397 | DB01037 | Selegiline | Amine oxidase [flavin-containing] A | small molecule | approved|investigational|vet_approved |
Top |
RelatedDiseases for OPHN1_MAOA |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | OPHN1 | C1136249 | Mental Retardation, X-Linked | 1 | CTD_human |
Tgene | MAOA | C0001973 | Alcoholic Intoxication, Chronic | 5 | PSYGENET |
Tgene | MAOA | C0005586 | Bipolar Disorder | 5 | PSYGENET |
Tgene | MAOA | C0011570 | Mental Depression | 5 | PSYGENET |
Tgene | MAOA | C0011581 | Depressive disorder | 5 | PSYGENET |
Tgene | MAOA | C0041696 | Unipolar Depression | 5 | PSYGENET |
Tgene | MAOA | C0525045 | Mood Disorders | 5 | PSYGENET |
Tgene | MAOA | C1269683 | Major Depressive Disorder | 5 | PSYGENET |
Tgene | MAOA | C0003431 | Antisocial Personality Disorder | 3 | CTD_human |
Tgene | MAOA | C0004352 | Autistic Disorder | 3 | CTD_human;HPO |
Tgene | MAOA | C0019151 | Hepatic Encephalopathy | 3 | CTD_human |
Tgene | MAOA | C0036341 | Schizophrenia | 2 | PSYGENET |
Tgene | MAOA | C0085762 | Alcohol abuse | 2 | PSYGENET |
Tgene | MAOA | C0270458 | Severe major depression with psychotic features | 2 | PSYGENET |
Tgene | MAOA | C2362914 | clinical depression | 2 | PSYGENET |
Tgene | MAOA | C0004936 | Mental disorders | 1 | CTD_human |
Tgene | MAOA | C0005587 | Depression, Bipolar | 1 | PSYGENET |
Tgene | MAOA | C0009241 | Cognition Disorders | 1 | CTD_human |
Tgene | MAOA | C0013415 | Dysthymic Disorder | 1 | PSYGENET |
Tgene | MAOA | C0014175 | Endometriosis | 1 | CTD_human |
Tgene | MAOA | C0020179 | Huntington Disease | 1 | CTD_human |
Tgene | MAOA | C0020649 | Hypotension | 1 | CTD_human |
Tgene | MAOA | C0026848 | Myopathy | 1 | CTD_human |
Tgene | MAOA | C0030567 | Parkinson Disease | 1 | CTD_human |
Tgene | MAOA | C0031511 | Pheochromocytoma | 1 | CTD_human |
Tgene | MAOA | C0033054 | Prenatal Exposure Delayed Effects | 1 | CTD_human |
Tgene | MAOA | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Tgene | MAOA | C0600427 | Cocaine Dependence | 1 | PSYGENET |
Tgene | MAOA | C0745744 | End Stage Liver Disease | 1 | CTD_human |
Tgene | MAOA | C1136249 | Mental Retardation, X-Linked | 1 | CTD_human |
Tgene | MAOA | C1285261 | Fetal Nutrition Disorders | 1 | CTD_human |
Tgene | MAOA | C2063866 | Depressive Disorder, Treatment-Resistant | 1 | PSYGENET |